<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        14-211-98
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1998
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ACCUZIDE 20 F.C.TAB
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        HYDROCHLOROTHIAZIDE, QUINAPRIL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        20, 12.5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        23.3
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="PFIZER" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            PFIZER
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 583]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ALNAGHI COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            PFIZER
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C09BA06
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Accuzide contains the active substances quinapril and hydrochlorothiazide. Quinapril belongs to a group of medicines called angiotensin converting enzyme (ACE) inhibitors. ACE inhibitors work by widening blood vessels in the body, which can help to reduce the pressure in the vessels. Hydrochlorothiazide belongs to a group of medicines called diuretics. Diuretics help the body to get rid of extra fluid and are used in patients with high blood pressure. Because they get rid of fluid, diuretics are sometimes called &lsquo;water tablets&rsquo;.</p><p>&nbsp;</p><p>Accuzide is used to treat high blood pressure.</p><p>&nbsp;</p><p>You must talk to a doctor if you do not feel better or if you feel worse.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take Accuzide</p><ul><li>if you have hereditary (inherited)/idiopathic (unknown cause) angioedema (a swelling of the face, tongue or throat which causes difficulty breathing)</li></ul><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are allergic to &nbsp;quinapril or hydrochlorothiazide or any of the other ingredients of this medicine (listed in section 6), similar medicines or to a group of antibiotics called sulfonamides</p><ul><li>if you have a history of angioedema relating to previous treatment with an ACE inhibitor</li></ul><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are in your second or third trimester of pregnancy</p><ul><li>if you have an obstruction in your heart that slows blood in the heart</li><li>if you have severe kidney disease or are experiencing problems passing water (anuria)</li><li>if you have been told after a blood test that you have high levels of potassium in your blood</li></ul><ul><li>if you have diabetes or impaired kidney function and you are being treated with a blood pressure lowering medicine containing aliskiren</li><li>if you are taking sacubitril/valsartan, a medicine for heart failure.</li></ul><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor or pharmacist before taking Accuzide, as this medicine may not be suitable for you:</p><p>&nbsp;</p><ul><li>if you have aortic stenosis (narrowing of the main blood vessel from the heart), low blood pressure, heart disease or other problems with your heart (e.g. heart failure)</li><li>if you have kidney disease, a transplanted kidney or use a haemodialysis machine (an artificial kidney), are being treated with diuretics, or have a salt-restrictive diet. This is because Accuzide may lower your blood pressure and cause you to feel faint</li><li>if you have liver disease</li><li>if you are elderly</li><li>if you have collagen vascular disease (deposits of collagen in your blood vessels)</li><li>if you have both kidney disease and collagen vascular disease. This is because Accuzide decreases the number of neutrophils and white blood cells in th<strong>e </strong>blood. Tell your doctor if you get symptoms such as sore throat or fever after taking Accuzide</li><li>if you are having, or about to have, low density lipoprotein apheresis treatment (removal of cholesterol from your blood by machine)</li><li>if you have parathyroid disease, this is a disease associated with increased calcium, decreased phosphate, development of kidney stones and stomach ulcers and reduction in bone strength</li><li>if you suffer from allergies or asthma</li><li>if you have suffered from angioedema in the past (red rash followed by facial swelling which can be severe enough to cause breathing difficulties)</li><li>if you have a history of severe allergic reactions such as swelling of the face, lips, tongue or throat or swelling of the hands or feet. This is because the taking of Accuzide may also cause severe swelling</li><li>if you are a black patient, this medicine might not work as well for you or you might be more likely to suffer serious side effects (e.g. angioedema)</li><li>if you have a salt or electrolyte imbalance in your blood (e.g. sodium or potassium), your doctor may want to monitor you more closely</li><li>if you suffer from hypokalaemia (low levels of potassium in your blood) symptoms of this are dryness of mouth, thirst, weakness, lethargy or muscle pain</li><li>if you are having, or about to have desensitisation treatment, i.e. to reduce the effects of an allergy to a bee or wasp sting</li><li>if you are planning to become pregnant, or you just became aware of being pregnant</li></ul><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have diabetes or gout</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have systemic lupus erythematosus (SLE) an allergic condition which causes joint pain, skin rashes and fever</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are about to have major surgery which requires an anaesthetic</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you develop visual problems such as eye pain or blurred vision while on Accuzide. The active ingredient, hydrochlorothiazide can cause you to develop visual problems. If this is not treated, it can lead to loss of vision. If you experience such symptoms, you should seek medical attention</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are also taking other medicines</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have lost a lot of body salts or fluids through being sick (vomiting), having diarrhoea, being on a low salt diet, taking diuretics (water tablets) for a long time or having had dialysis</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a rapid swelling of the wall of the bowels (intestines) can occur when taking Accuzide. Patients can experience abdominal pain with or without vomiting</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are taking any of the following medicines used to treat high blood pressure:</p><p>- an angiotensin II receptor blocker (ARBs) (also known as sartans - for example valsartan, telmisartan, irbesartan), in particular if you have diabetes-related kidney problems</p><p>- aliskiren</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are simultaneously receiving an mTOR (mammalian target of Rapamycin) inhibitor (e.g. temsirolimus) or a DPP-4 (dipeptidyl-peptidase-4) inhibitor (e.g. vildagliptin) or a neutral endopeptidase inhibitor (e.g. racecadotril), may have an increased risk for angioedema (swelling of the face, eyes, tongue or throat). Special caution is advised if treatment with an mTOR inhibitor or DPP-4 inhibitor or a neutral endopeptidase inhibitor is initiated in patients who are already receiving an ACE inhibitor.</p><p>&nbsp;</p><p>Your doctor may check your kidney function, blood pressure, and the amount of electrolytes (e.g. potassium) in your blood at regular intervals.</p><p>&nbsp;</p><p>See also information under the heading <strong>Do not take Accuzide</strong>.</p><p>&nbsp;</p><p><strong>Other medicines and Accuzide</strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.</p><p>&nbsp;</p><p>There are some medicines that may interact with Accuzide. Your doctor may need to change your dose and/or take other precautions if you are taking:</p><p>&nbsp;</p><ul><li>angiotensin II receptor blocker (ARB) or aliskiren (see also information under the headings <strong>Do not take Accuzide</strong> and <strong>Warnings and precautions</strong>)</li><li>other blood pressure treatments and diuretics (including aliskiren and water tablets)</li><li>antibiotics like sulfamethoxazole, trimethoprim and tetracycline antibiotics</li><li>potassium supplements (this includes salt substitutes which often contain potassium)</li><li>anaesthetics</li><li>lithium (used to treat depression, mania or self-harming behaviour)</li><li>non-steroidal anti-inflammatory pain killers (for example aspirin or ibuprofen)</li><li>corticosteroids (for example hydrocortisone, dexamethasone or prednisolone) and ACTH (tetracosactide) or medicines known to reduce the amount of potassium in the blood</li><li>procainamide (used to correct irregular heartbeats)</li><li>cytostatic medicines (cancer therapy)</li><li>immunosuppressants (for the treatment of autoimmune diseases such as Crohn&rsquo;s disease and rheumatoid arthritis)</li><li>allopurinol, uricosurics and xanthine oxidase inhibitors (for the treatment of chronic gout)</li><li>indigestion and heartburn medicines (antacids)</li><li>&lsquo;pressor amines&rsquo; such as norepinephrine or other medicines from the same group</li><li>medicines that have a sedative effect. This includes alcoholic drinks and sleeping pills</li><li>medicine for an irregular heart rhythm e.g. digoxin, amiodarone or sotalol</li><li>medicines that can be used to reduce cholesterol or bile salts (cholestyramine and colestipol)</li><li>medicines to treat diabetes such as insulin or tablets. You may need to alter your dose of insulin while taking Accuzide</li></ul><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines such as digitalis glycosides (digoxin) or any medicines used for the treatment of ventricular tachycardia. Tachycardia is a condition where the heart rate beats faster than normal. Care should be taken when Accuzide is taken together because of the potential risk of low concentrations of potassium in the blood</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; mTOR inhibitors used to treat kidney cancer (including temsirolimus), certain antidiabetic drugs (DPP-4 inhibitors e.g. vildagliptin) or certain drugs against heart insufficiency and high blood pressure (neutral endopeptidase inhibitor, e.g. racecadotril): the risk of an angioedema (swelling of the face, eyes, tongue or throat) can be elevated.</p><p>&nbsp;</p><p><strong>Surgery</strong></p><p>Remember to tell any medical staff that you are taking Accuzide. This is important if you go into hospital for an operation as your anaesthetist will want to know.</p><p><strong>&nbsp;</strong></p><p><strong>Laboratory Tests</strong></p><p>Accuzide may affect the results of some laboratory tests. Tell your doctor or hospital staff that you are taking Accuzide if you need to have any tests carried out by your doctor or in hospital.</p><p>&nbsp;</p><p><strong>Accuzide with food and drink</strong></p><p>See section 3 <strong>How to take Accuzide</strong>.</p><p>&nbsp;</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p>Do not start taking Accuzide if you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby. Ask your doctor for advice before taking this medicine.</p><p>Your doctor will normally advise you to stop taking Accuzide before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of Accuzide. Accuzide is not recommended during pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy. Accuzide is not recommended for mothers who are breast-feeding.</p><p><strong>When pregnancy is detected, discontinue Accuzide as soon as possible.</strong></p><p><strong>Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.</strong></p><p>&nbsp;</p><p><strong>Driving and using machines</strong></p><p>Your tablets may affect your ability to drive or operate machinery safely. They may make you feel dizzy or weary. If affected, do not drive or operate machinery and contact your doctor immediately.</p><p>&nbsp;</p><p><strong>Accuzide contains lactose</strong></p><p>Accuzide contains lactose (a type of sugar), if you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p>&nbsp;</p><p>The recommended dose of Accuzide is one tablet each day. Try to take the tablet at about the same time every day. Accuzide can be taken with or without food.</p><p>&nbsp;</p><p>Accuzide should not be used in children and adolescents under 18 years of age.</p><p>&nbsp;</p><p>Accuzide is not recommended for use in patients who suffer with kidney disease with a creatinine clearance of less than 40 ml/min.</p><p>&nbsp;</p><p>In the elderly, adequate blood pressure control should be achieved with the lowest possible dose<em>.</em></p><p>&nbsp;</p><p>Swallow the tablets whole with water. <strong>Do not chew, divide</strong> or <strong>crush </strong>the tablets.</p><p>The score line is only there to help you break the tablet if you have difficulty swallowing it whole.</p><p>&nbsp;</p><p>If you are still not sure, ask your doctor or pharmacist.</p><p>&nbsp;</p><p>It is important to keep taking your tablets. They help to control your blood pressure.</p><p>&nbsp;</p><p>Don&#39;t wait until your tablets are finished before seeing your doctor.</p><p>&nbsp;</p><p><strong>If you take more Accuzide than you should</strong></p><p>Taking too many tablets at once may make you unwell. If you take too many Accuzide tablets, tell your doctor or go to your nearest hospital casualty department immediately. Take along any tablets that are left, the packaging and the label so that the hospital staff can easily tell what medicine you have taken.</p><p>&nbsp;</p><p><strong>If you forget to take Accuzide</strong></p><p>Do not worry. If you forget to take a dose, miss out the forgotten dose completely and take the next dose at the normal time. <strong>Do not take a double dose</strong> to make up for a forgotten dose.</p><p>&nbsp;</p><p><strong>If you stop taking Accuzide</strong></p><p>Do not stop taking your medicine or alter the dose you are currently taking without seeing your doctor first.</p><p>&nbsp;</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects although not everybody gets them.</p><p>&nbsp;</p><p><strong>STOP</strong> <strong>taking Accuzide and call an ambulance immediately </strong>if you experience any of the following symptoms. Although they are very rare, they can be serious.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe allergic (anaphylactoid) reactions such as swelling of the face, lips, tongue or throat (angioedema) which may cause great difficulty breathing; swelling of the extremities (hands and feet).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe abdominal pain and/or back pain causing you to feel or be sick (this may be a sign of an inflamed intestine or an inflamed pancreas).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chest pain or tightness, shortness of breath or racing of the heart. These could be symptoms of a heart attack or other heart problem.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Weakness of arms, legs or problems speaking which may be symptoms of a possible stroke.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Serious, potentially life threatening skin rashes including hives, severe itching, blistering, peeling and swelling of the skin, inflammation of mucous membranes (Stevens Johnson Syndrome), toxic epidermal necrolysis (TEN) and pemphigus.</p><p>&nbsp;</p><p>Tell your doctor <strong>immediately </strong>if you experience any of the following symptoms after taking Accuzide. Although they are very rare, these symptoms can be serious.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling faint, particularly when standing; this may mean your blood pressure is too low (hypotension). This is more likely to occur if you have been taking diuretics (water tablets), other blood pressure medication in addition to Accuzide, alcohol, or if you are dehydrated or are on dialysis. If you feel light headed or faint, lie down until this feeling passes.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe sore throat or severe mouth ulcers, particularly if you suffer from kidney problems or collagen vascular disease. You may not have enough of certain white blood cells (neutropenia/agranulocytosis) which may lead to increased risk of infection or fever.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chest pain, angina, tightness of the chest, shortness of breath, wheezing or trouble breathing, irregular or strong heartbeat (palpitations).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Yellowing of the skin or the eyes (jaundice) which may be a sign of liver inflammation (hepatitis).</p><p>&nbsp;</p><p>The following side effects have also been reported in patients with high blood pressure being treated with Accuzide:</p><p><strong>&nbsp;</strong></p><p><strong>Common side effects: may affect up to 1 in 10 people</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diarrhoea, indigestion, mild stomach pain, feeling or being sick</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dizziness, headache, feeling weak, tiredness, sleepiness or sleeplessness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; painful muscles, muscle weakness, back pain</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; high levels of uric acid in your blood causing swollen, painful joints (gout)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; coughing, bronchitis</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nose or throat infections, nasal stuffiness and/or runny nose (rhinitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; widening of blood vessels</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; chest pain</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the throat</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased levels of creatinine in the serum. This is a waste molecule that is produced from muscle metabolism</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased levels of nitrogen in the blood, that comes from the waste product urea</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased potassium in the blood</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; awareness of the heart beat</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased heart rate</p><p>&nbsp;</p><p><strong>Uncommon side effects: may affect up to 1 in 100 people</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; kidney and urinary problems, urinary tract infection</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; numbness or tingling sensation in your limbs</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; aching joints</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; depression, nervousness, confusion</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ringing or noise in the ears</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; wind</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; lazy eye</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling of spinning or rotation of surroundings (vertigo)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fainting, low blood pressure</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dry mouth or throat, taste disturbances</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fluid retention in the body</p><ul><li>angioedema (a swelling of the face, tongue or throat which causes difficulty breathing)</li></ul><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of your sinuses (sinusitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling hot (fever), increased sweating</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hair loss, itching, sensitivity of skin to light</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; failure/inability to achieve penile erection</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; viral infection</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shortness of breath</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; mild form of diabetes</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; protein in urine</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; mini-stroke</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart attack</p><p>&nbsp;</p><p><strong>Rare side effects: may affect up to 1 in 1,000 people</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; problems with balance</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the lungs which can cause breathlessness, cough and raised temperature</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; constipation</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the tongue</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of blood vessels</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin blisters</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; psoriasis</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin disorders associated with fever, muscle and joint pain</p><p>&nbsp;</p><p><strong>Very Rare side effects: may affect up to 1 in 10,000</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; obstruction of the digestive system (bowel), swelling or fluid in the small bowel</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blurred vision</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hives</p><p>&nbsp;</p><p><strong>Not known: frequency cannot be established from the available data</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; allergic condition which can cause joint, skin and organ problems (systemic lupus erythematosus)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin discolouration</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; itching and scaling of the skin</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin peeling and lesions</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; damage to the skin tissue</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in numbers of white blood cells or decrease in blood platelets which may result in bruising or easy bleeding, low numbers of red blood cells (anaemia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; bleeding or blockage of the blood vessels in the brain (stroke)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; narrowing of the airways in the lungs (bronchospasm)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; effects results of blood or other laboratory tests</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased numbers of blood cells involved in allergic diseases</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; serious allergic reaction</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the liver</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; yellowing of the skin or the eyes</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the pancreas</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; immune system condition affecting the skin and mucous membranes</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the kidneys</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the lining of the lungs, heart or abdomen</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; irregular heart beat</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reduced blood pressure when standing</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; short-sightedness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; acute closure glaucoma (increased pressure in the eyes)</p><p>&nbsp;</p><p>Accuzide may cause certain changes in your blood and your doctor may do blood tests to monitor this. If you notice bruising, feeling very tired or if you are diabetic and notice changes in your sugar levels let your doctor know so blood tests can be arranged if necessary.</p><p>&nbsp;</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed at the end of this Patient Information Leaflet. By reporting side effects you can help provide more information on the safety of this medicine.</p><p>&nbsp;</p><p><u>National reporting system</u>:</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>National Pharmacovigilance Centre ( NPC )</p><p>&middot;&nbsp;&nbsp;&nbsp; Fax: +966 11 205 7662</p><p>&middot;&nbsp;&nbsp;&nbsp; Call NPC at 00966 11 2038222, Exts: 2317-2356-2340</p><p>&middot;&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><p>&middot;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&middot;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa/</p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>&nbsp;</p><p>Do not use Accuzide after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of that month.</p><p>&nbsp;</p><p>Shelf life: 2 years</p><p>&nbsp;</p><p>Store below 25&deg;C. Store in the original package.</p><p>&nbsp;</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substances in Accuzide are quinapril and hydrochlorothiazide. Each tablet contains 20 mg of quinapril (present as 21.70 mg quinapril hydrochloride) and 12.5&nbsp;mg of hydrochlorothiazide.</p><p>&nbsp;</p><p>The tablets also contain the inactive ingredients: magnesium carbonate, lactose monohydrate, povidone, crospovidone and magnesium stearate.</p><p>The coating of the tablets contains candelilla wax and opadry pink OY-S-6937 which contains iron oxide (E172), titanium dioxide (E171), hydroxypropyl methyl cellulose, hydroxypropyl cellulose and polyethylene glycol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Accuzide tablets are oval pink, film coated tablets scored on both sides. 

The tablets are available in carton of 30 tablets. 


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorisation Holder</strong><strong> </strong>&nbsp;</p><p>&nbsp;</p><p>Pfizer Pharma PFE GmbH, Berlin, Germany</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp; Manufacture</strong><strong>d PACKED &amp; RELEASED BY</strong></p><p>&nbsp;</p><p>&nbsp;</p><p>Pfizer Manufacturing Deutschland GmbH</p><p>Betriebsst&auml;tte Freiburg</p><p>Mooswaldallee 1</p><p>79090 Freiburg</p><p>Germany</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised March 2018.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p style="direction: rtl;">أكيوزايد</p><p style="direction: rtl;">يحتوي أكيوزايدعلى المادتين الفعالتين كوينابريل وهيدروكلوروثيازايد. ينتمي كوينابريل إلى مجموعة من الأدوية تُسمى مثبطات الإنزيم المحول للأنجيوتنسين (ACE). تعمل مثبطات الإنزيم المحول للأنجيوتنسين من خلال توسيع الأوعية الدموية في الجسم، مما يساعد على تقليل الضغط في الأوعية. ينتمي هيدروكلوروثيازايد إلى مجموعة أدوية يطلق عليها مدرات البول. تساعد مدرات البول الجسم على التخلص من السوائل الزائدة وتُستخدم مع المرضى الذين يعانون من ضغط الدم المرتفع. تُسمَّى مدرات البول أحيانًا &quot;أقراص الماء&quot;، نظرًا لأنها تتخلص من السوائل.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">يُستخدم أكيوزايد لعلاج ضغط الدم المرتفع.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">يجب أن تتحدث إلى أحد الأطباء إذا لم تشعر بتحسن أو إذا ساءت حالتك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;">لا تتناول أكيوزايد</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من وذمة وعائية وراثية (موروثة)/مجهولة السبب (وهي عبارة عن تورم الوجه أو اللسان أو الحلق مما يؤدي إلى صعوبة في التنفس)</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">&middot;&nbsp; إذا كنت مصابًا بالحساسية تجاه كوينابريل أو هيدروكلوروثيازايد أو أي مكون آخر من مكونات هذا الدواء (المدرجة في القسم 6) أو تجاه الأدوية المماثلة أو تجاه مجموعة من المضادات الحيوية تُسمى السلفوناميدات</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك تاريخ من الإصابة بالوذمة الوعائية مرتبط بعلاج سابق بأحد مثبطات الإنزيم المحول للأنجيوتنسين</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">&middot;&nbsp; إذا كنتِ في الثُلُث الثاني أو الثالث من الحمل</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من انسداد في قلبك يسبب بطء تدفق الدم إلى القلب</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">&middot;&nbsp; إذا كنت تعاني من مرض شديد بالكلى أو كنت تعاني من مشكلات في التبول (انقطاع البول)</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">&middot;&nbsp; إذا تم إخبارك بعد خضوعك لفحص دم بأن لديك مستويات مرتفعة من البوتاسيوم في دمك</p><p style="direction: rtl;"><strong>&nbsp;</strong></p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">&middot;&nbsp; إذا كنت تعاني من السكري أو من خلل في وظائف الكلى وتتلقى علاجًا بدواء خافض لضغط الدم يحتوي على أليسكيرين</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">&middot;&nbsp; إذا كنت تتناول ساكوبتريل/فالسارتان، وهو دواء لعلاج فشل القلب.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>تحذيرات واحتياطات</strong></p><p style="direction: rtl;"><strong>&nbsp;</strong></p><p style="direction: rtl;">استشر طبيبك أو الصيدلي قبل تناول أكيوزايد، حيث إن الدواء قد لا يكون مناسبًا لك:</p><p style="direction: rtl;">&nbsp;</p><ul><li style="direction: rtl;">إذا كنت تعاني من كنت تعاني من تضيق الأورطي (تضيق وعاء الدم الرئيسي الذي يخرج من القلب)، أو ضغط دم منخفض، أو مرض بالقلب أو مشكلات أخرى متعلقة بقلبك (مثل فشل القلب)</li><li style="direction: rtl;">إذا كنت تعانى من مرض بالكلى، أو لديك كلية مزروعة أو تستخدم جهازًا للديلزة الدموية (كلية صناعية)، أو تخضع للعلاج بمدرات البول، أو تتبع حمية غذائية ذات كميات مقيدة من الملح. وذلك نظرًا لأن أكيوزايد قد يخفض من ضغط دمك ويسبب لك الشعور بالإغماء</li><li style="direction: rtl;">إذا كنت تعاني من مرض بالكبد</li><li style="direction: rtl;">إذا كنت من كبار السن</li><li style="direction: rtl;">كنت تعاني من مرض وعائي كولاجيني (وجود ترسبات من الكولاجين في أوعيتك الدموية)</li><li style="direction: rtl;">إذا كنت تعاني من كلٍ من مرض بالكلى ومرض وعائي كولاجيني. وذلك نظرًا لأن أكيوزايد يخفض من عدد العدلات وخلايا الدم البيضاء في الدم. أخبر طبيبك إذا تعرضت لأعراض مثل التهاب الحلق أو الحمى بعد تناول أكيوزايد</li><li style="direction: rtl;">إذا كنت تخضع أو على وشك الخضوع للعلاج بإجراء فصادة البروتين الدهني منخفض الكثافة (إزالة الكولستيرول من جسمك بواسطة جهاز)</li><li style="direction: rtl;">إذا كنت تعاني من مرض بالغدة الجار درقية، وهو مرض مرتبط بزيادة الكالسيوم، وانخفاض الفوسفات، وتكون حصوات الكلى وقرح المعدة وانخفاض قوة العظام</li></ul><p style="direction: rtl;"><strong>&nbsp;</strong></p><ul><li style="direction: rtl;">إذا كنت تعاني من أي نوع حساسية أو ربو</li><li style="direction: rtl;">إذا كنت قد عانيت من وذمة وعائية في الماضي (طفح جلدي أحمر يتبعه تورم في الوجه والذي قد يكون شديدًا بما يكفي ليسبب صعوبات في التنفس)</li><li style="direction: rtl;">إذا كان لديك تاريخ من تفاعلات الحساسية الشديدة مثل تورم الوجه، أو الشفتين، أو اللسان، أو الحلق أو تورم اليدين أو القدمين. وذلك لأن تناول أكيوزايد قد يسبب أيضًا تورمًا شديدًا</li><li style="direction: rtl;">إذا كنت مريضًا من أصحاب البشرة السوداء، فقد لا يعمل هذا الدواء بنفس الكفاءة بالنسبة لك أو قد يكون من الأرجح أن تعاني من آثار جانبية خطيرة (مثل الوذمة الوعائية)</li><li style="direction: rtl;">إذا كنت تعاني من عدم توازن الأملاح أو الإلكتروليتات في دمك (مثل الصوديوم أو البوتاسيوم)، فقد يرغب طبيبك في مراقبتك عن كثب بشكل أكبر</li><li style="direction: rtl;">إذا كنت تعاني من نقص بوتاسيوم الدم (انخفاض مستويات البوتاسيوم في دمك) وأعراضه هي جفاف الفم، أو العطش، أو الضعف، أو الخمول، أو ألم العضلات</li><li style="direction: rtl;">إذا كنت تخضع أو على وشك الخضوع لعلاج إزالة الحساسية، أي تقليل تأثيرات الحساسية تجاه لدغة نحلة أو دبور</li><li style="direction: rtl;">إذا كنتِ تخططين للحمل أو عرفتي لتوكِ أنكِ حامل</li></ul><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من السكري أو النقرس</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا بمرض الذئبة الحمراء &quot;سيستمك لوباس ايريثماتوزيس&quot; (SLE) وهي حالة حساسية تسبب ألم المفاصل وطفح جلدي وحمى</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت على وشك الخضوع لجراحة كبرى والتي تتطلب الخضوع للتخدير</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا أصبت بمشكلات في الرؤية مثل ألم في العين أو تغيم الرؤية أثناء تناولك لأكيوزايد. فالمكون الفعال، هيدروكلوروثيازايد، يمكن أن يتسبب في إصابتك بمشكلات في الرؤية. إذا لم تُعالج هذه الأعراض، فقد تؤدي إلى فقدان الرؤية. إذا تعرضت لهذه الأعراض، ينبغي عليك طلب الرعاية الطبية</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تتناول أيضًا أدوية أخرى</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت قد <strong>فقدت الكثير من أملاح الجسم أو سوائله</strong> عن طريق القيء، أو الإصابة بالإسهال، أو الالتزام بحمية غذائية منخفضة الملح، أو تناول مدرات البول (أقراص الماء) لمدة طويلة أو الخضوع للديلزة</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يحدث تورم سريع لجدار الأمعاء عند تناول أكيوزايد. يمكن أن يتعرض المرضى لألم بالبطن يصحبه أو لا يصحبه قيء</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تتناول أيًا من الأدوية التالية المُستخدمة لعلاج ضغط الدم المرتفع:- أحد حاصرات مستقبلات الأنجيوتنسين II &rlm;(ARBs) (المعروفة كذلك باسم السارتانات، مثل فالسارتان، وتيلميسارتان، وإيربيسارتان) وخاصةً إذا كنت تعاني من مشكلات في الكلى مرتبطة بمرض السكري.</p><p style="direction: rtl;">- أليسكيرين</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تتلقى بشكل متزامن أحد المثبطات الانتقائية للهدف الثديي لراباميسين (mTOR) (مثل تمسيروليموس) أو مثبط ببتيداز ثنائي الببتيديل -4 (DPP-4) (مثل فيلداجليبتين) أو أحد مثبطات الببتيداز الداخلية المتعادلة (مثل راسيكادوتريل)، فقد تكون معرضًا لخطر متزايد للإصابة بالوذمة الوعائية (تورم الوجه أو العينين أو اللسان أو الحلق). يُنصح بتوخي الحذر بشكل خاص إذا تم بدء العلاج بأحد المثبطات الانتقائية للهدف الثديي لراباميسين أو مثبط ببتيداز ثنائي الببتيديل -4 أو أحد مثبطات الببتيداز الداخلية المتعادلة في المرضى الذين يتلقون بالفعل مثبط الإنزيم المحول للأنجيوتنسين.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">قد يقوم طبيبك بفحص وظائف كليتيك، وضغط دمك، وكمية الإلكتروليتات (مثل البوتاسيوم) في دمك على فترات منتظمة.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">انظر أيضًا المعلومات الموجودة تحت عنوان &quot;لا تتناول أكيوزايد&quot;.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>الأدوية الأخرى وأكيوزايد</strong></p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">أخبر طبيبك أو الصيدلي إذا كنت تتناول أو تناولت مؤخرًا أو قد تتناول أي أدوية أخرى، بما في ذلك الأدوية التي يتم الحصول عليها دون وصفة طبية.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">فهناك بعض الأدوية التي قد تتفاعل مع أكيوزايد. وقد يحتاج طبيبك إلى تغيير جرعتك و/أو اتخاذ احتياطات أخرى إذا كنت تتناول:</p><p style="direction: rtl;">&nbsp;</p><ul><li style="direction: rtl;">حاصرات مستقبلات الأنجيوتنسين II&rlm; (ARB) أو أليسكيرين (انظر أيضًا المعلومات الموجودة تحت العنوانين &quot;لا تتناول أكيوزايد&quot; و&quot;تحذيرات واحتياطات&quot;)</li></ul><p style="direction: rtl;">&nbsp;</p><ul><li style="direction: rtl;">علاجات ضغط الدم ومدرات البول الأخرى (بما في ذلك أليسكيرين وأقراص الماء)</li></ul><p style="direction: rtl;">&nbsp;</p><ul><li style="direction: rtl;">المضادات الحيوية مثل سلفاميثوكسازول، وترايميثوبريم والمضادات الحيوية التتراسيكلينية</li></ul><p style="direction: rtl;"><strong>&nbsp;</strong></p><ul><li style="direction: rtl;">مكملات البوتاسيوم (تتضمن بدائل الملح التي عادةً ما تحتوي على البوتاسيوم)</li></ul><p style="direction: rtl;">&nbsp;</p><ul><li style="direction: rtl;">المواد المخدرة</li></ul><p style="direction: rtl;"><strong>&nbsp;</strong></p><ul><li style="direction: rtl;">الليثيوم (يستخدم لعلاج الاكتئاب، أو الهوس، أو سلوكيات إيذاء النفس)</li></ul><p style="direction: rtl;"><strong>&nbsp;</strong></p><ul><li style="direction: rtl;">مسكنات الألم المضادة للالتهاب غير الستيرويدية (مثل أسبرين أو إيبوبروفين)</li></ul><p style="direction: rtl;"><strong>&nbsp;</strong></p><ul><li style="direction: rtl;">الستيرويدات القشرية (مثل هيدروكورتيزون أو ديكساميثازون أو بريدنيزولون) والهرمون الموجه لقشر الكظر (ACTH) (تتراكوساكتيد) أو الأدوية المعروفة بتقليل كمية البوتاسيوم في الدم</li></ul><p style="direction: rtl;"><strong>&nbsp;</strong></p><ul><li style="direction: rtl;">بروكايناميد (يستخدم لتصحيح ضربات القلب غير المنتظمة)</li></ul><p style="direction: rtl;">&nbsp;</p><ul><li style="direction: rtl;">الأدوية المثبطة لانقسام الخلايا (علاج السرطان)</li></ul><p style="direction: rtl;">&nbsp;</p><ul><li style="direction: rtl;">مثبطات المناعة (لعلاج أمراض المناعة الذاتية مثل مرض كرون والتهاب المفاصل الروماتويدي)</li></ul><p style="direction: rtl;">&nbsp;</p><ul><li style="direction: rtl;">ألوبورينول، والأدوية المدرة لليوريك، ومثبطات إنزيم أكسيداز-زانثاين (لعلاج النقرس المزمن)</li></ul><p style="direction: rtl;">&nbsp;</p><ul><li style="direction: rtl;">أدوية عسر الهضم وحرقة فم المعدة (مضادات الحموضة)</li></ul><p style="direction: rtl;">&nbsp;</p><ul><li style="direction: rtl;">&quot;الأمينات الرافعة للضغط&quot; مثل نورإبينفرين أو الأدوية الأخرى من نفس المجموعة</li></ul><p style="direction: rtl;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><ul><li style="direction: rtl;">الأدوية ذات التأثير المهدئ. تتضمن هذه الأدوية المشروبات الكحولية والحبوب المنومة</li></ul><p style="direction: rtl;">&nbsp;</p><ul><li style="direction: rtl;">دواء لعلاج عدم انتظام ضربات القلب مثل ديجوكسين، أو أميودارون، أو سوتالول</li></ul><p style="direction: rtl;">&nbsp;</p><ul><li style="direction: rtl;">الأدوية التي يمكن استخدامها لتقليل الكوليسترول أو أملاح الصفراء (كوليستيرامين أو كوليستيبول)</li></ul><p style="direction: rtl;">&nbsp;</p><ul><li style="direction: rtl;">أدوية علاج داء السكري مثل الإنسولين أو الأقراص. قد تحتاج لتغيير جرعتك من الإنسولين أثناء تناولك أكيوزايد</li></ul><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أكيوزايدأدوية مثل جليكوزيدات الديجيتاليس (ديجوكسين) أو أي أدوية تستخدم لعلاج تسرع القلب البطيني. تسرع القلب هو حالة يكون فيها معدل ضربات القلب أسرع من الطبيعي. ينبغي توخي الحذر عند تناول أكيوزايد بشكل متزامن بسبب الخطر المحتمل لانخفاض تركيزات البوتاسيوم في الدم</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المثبطات الانتقائية للهدف الثديي لراباميسين (mTOR) المُستخدمة لعلاج سرطان الكلى (بما في ذلك تمسيروليموس)، عقاقير معينة مضادة للسكري (مثبطات ببتيداز ثنائي الببتيديل -4 مثل فيلداجليبتين) أو عقاقير معينة ضد قصور القلب وضغط الدم المرتفع (مثبط الببتيداز الداخلية المتعادل مثل راسيكادوتريل): يمكن أن يتزايد خطر الوذمة الوعائية (تورم الوجه أو العينين أو اللسان أو الحلق).</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>الجراحة</strong></p><p style="direction: rtl;">تذكر أن تخبر أي طاقم عمل طبي بأنك تتناول أكيوزايد. وهذا مهم إذا ذهبت للمستشفى للخضوع لعملية جراحية حيث أن طبيب التخدير الخاص بك سيرغب في معرفة هذا الأمر.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>الاختبارات المعملية</strong></p><p style="direction: rtl;">قد يؤثر أكيوزايد على نتائج بعض الاختبارات المعملية. أخبر طبيبك أو طاقم العمل بالمستشفى أنك تتناول أكيوزايد إذا كنت بحاجة للخضوع لأي اختبارات يجريها طبيبك أو تُجرى في المستشفى.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>أكيوزايد مع الطعام والشراب</strong></p><p style="direction: rtl;">انظر القسم 3 &quot;كيفية تناول أكيوزايد&quot;.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>الحمل والرضاعة الطبيعية والخصوبة</strong></p><p style="direction: rtl;">لا تتناولي أكيوزايد إذا كنتِ حاملًا أو ترضعين رضاعة طبيعية، أو كنتِ تعتقدين أنكِ ربما تكونين حاملًا أو كنتِ تخططين للحمل، واستشيري طبيبكِ قبل تناول هذا الدواء.</p><p style="direction: rtl;">سوف ينصحكِ طبيبكِ عامةً بإيقاف تناول أكيوزايد قبل أن تصبحي حاملًا أو بمجرد معرفتكِ أنكِ حامل وسوف ينصحكِ بتناول دواء آخر بدلًا من أكيوزايد. لا يوصى بتناول أكيوزايد خلال الحمل ويجب عدم تناوله عندما تكونين حاملًا لأكثر من 3 أشهر، لأنه قد يسبب ضررًا خطيرًا لطفلكِ في حالة تناوله بعد الشهر الثالث من الحمل. لا يوصى بتناول أكيوزايد للأمهات اللاتي ترضعن أطفالهن رضاعة طبيعية.</p><p style="direction: rtl;"><strong>عند اكتشاف الحمل، توقفي عن تناول أكيوزايد بأسرع ما يمكن.</strong></p><p style="direction: rtl;"><strong>العقاقير التي تعمل بشكل مباشر على نظام رينين-أنجيوتنسين يمكنها أن تسبب الإصابة والوفاة للجنين في مرحلة تكوينه.</strong></p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>القيادة واستخدام الآلات</strong></p><p style="direction: rtl;">قد تؤثر أقراصك على قدرتك على القيادة أو تشغيل الآلات بأمان. فقد تجعلك تشعر بالدوار أو الإنهاك. إذا ما تعرضت لذلك، فتجنب القيادة أو تشغيل الآلات واتصل بطبيبك على الفور.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>يحتوي أكيوزايد على لاكتوز</strong></p><p style="direction: rtl;">يحتوي أكيوزايد على اللاكتوز (نوع من أنواع السكر)، وإذا أخبرك طبيبك أنك مصاب بعدم تحمل لبعض السكريات، فاتصل به قبل تناول هذا المنتج الدوائي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;">احرص دومًا على تناول هذا الدواء تمامًا كما أخبرك طبيبك أو الصيدلي. استشر طبيبك أو الصيدلي إذا لم تكن متأكدًا مما يجب عليك فعله.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">الجرعة الموصى بها من أكيوزايد هي قرص واحد كل يوم. حاول أن تتناول القرص في نفس التوقيت تقريبًا كل يوم. يمكن تناول أكيوزايد مع الطعام أو دونه.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">لا تستخدم أكيوزايد مع الأطفال والمراهقين الأصغر من 18 عامًا.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">يوصى بعدم استخدام أكيوزايد مع المرضى الذين يعانون من مرض بالكلى والذين يبلغ معدل تصفية الكرياتينين لديهم أقل من 40 مل/دقيقة.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">بالنسبة لكبار السن، ينبغي التحكم في ضغط الدم بشكل مناسب بأقل جرعة ممكنة<em>.</em></p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">ابتلع القرص كاملًا مع الماء. <strong>لا تمضغ الأقراص أو تقسمها</strong> أو <strong>تطحنها</strong>.</p><p style="direction: rtl;">الخط المحزز موجود فقط لمساعدتك على كسر القرص إذا كنت تواجه صعوبة في ابتلاعه بالكامل.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">إذا كنت لا تزال غير متأكد، فاسأل طبيبك أو الصيدلي.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">يجب عليك الاستمرار في تناول أقراصك. فهي تساعد على التحكم في ضغط دمك.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">لا تنتظر حتى انتهاء أقراصك قبل زيارتك للطبيب.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>إذا تناولت جرعة من أكيوزايد أكبر مما ينبغي</strong></p><p style="direction: rtl;">قد يتسبب تناولك العديد من الأقراص في آن واحد في شعورك بالتوعك. إذا تناولت كمية من أقراص أكيوزايد أكبر مما ينبغي، فأخبر طبيبك أو توجه إلى قسم الإصابات بأقرب مستشفى على الفور. خذ معك أي اقراص متبقية بالإضافة إلى العبوة والملصق حتى يتسنى لطاقم العمل بالمستشفى معرفة الدواء الذي تناولته بسهولة.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>إذا نسيت تناول أكيوزايد:</strong></p><p style="direction: rtl;">لا تقلق. إذا نسيت تناول إحدى الجرعات، فقم بتخطي الجرعة المنسية تمامًا وتناول الجرعة التالية في الوقت المعتاد. <strong>لا تتناول جرعة مضاعفة</strong> لتعويض جرعة منسية.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>إذا توقفت عن تناول أكيوزايد:</strong></p><p style="direction: rtl;">لا تتوقف عن تناول دوائك ولا تقم بتغيير الجرعة التي تتناولها حاليًا دون الرجوع لطبيبك أولًا.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">إذا كان لديك مزيد من الأسئلة بشأن استخدام هذا الدواء، فاسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;">كما هو الحال بالنسبة لجميع الأدوية، قد يسبب هذا الدواء آثارًا جانبية، غير أنها لا تصيب الجميع.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>توقف</strong> <strong>عن تناول أكيوزايد واطلب الإسعاف فورًا </strong>إذا أصبت بأي من الأعراض التالية. وعلى الرغم من أن هذه الأعراض نادرة جدًا، إلا إنها قد تكون خطيرة.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات حساسية شديدة (تفاعلات تأقانية) مثل تورم الوجه أو الشفتين أو اللسان أو الحلق (الوذمة الوعائية) مما قد يسبب صعوبة كبيرة في التنفس؛ تورم الأطراف (اليدين والقدمين).</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم شديد بالبطن و/أو الظهر يجعلك تشعر بالغثيان أو تصاب بالقيء (قد يكون هذا مؤشرًا على وجود التهاب في الأمعاء أو البنكرياس).</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم أو ضيق بالصدر أو ضيق التنفس أو تسارع القلب. قد تكون هذه أعراضًا لأزمة قلبية أو مشكلات أخرى في القلب.</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضعف في الذراعين أو الساقين أو مشكلات في التحدث، والتي من المحتمل أن تكون أعراضًا لسكتة دماغية.</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي خطير يمكن أن يكون مهددًا للحياة بما في ذلك الشرى والحكة الشديدة وتبثر الجلد وتقشره وتورمه والتهاب الأغشية المخاطية (متلازمة ستيفنز جونسون) وتقشر الأنسجة المتموتة البشروية التسممي (TEN) والفقاع.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">أخبر طبيبك <strong>على الفور </strong>إذا أصبت بأي من الأعراض التالية بعد تناول أكيوزايد. وعلى الرغم من أن هذه الأعراض نادرة جدًا، إلا إنها قد تكون خطيرة.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالضعف، خاصةً عند الوقوف، وقد يعني ذلك أن ضغط دمك منخفض للغاية (انخفاض ضغط الدم). يحدث ذلك على الأرجح إذا كنت تتناول مدرات البول (أقراص الماء) أو أدوية أخرى لضغط الدم بالإضافة إلى أكيوزايد أو كنت تتناول الكحوليات أو تعاني من الجفاف أو كنت تخضع للديلزة. إذا شعرت بالدوخة أو الدوار، فاستلق حتى يزول هذا الشعور.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب شديد في الحلق أو قرح شديدة في الفم، خاصة إذا كنت تعاني من مشكلات بالكلى أو من مرض وعائي كولاجيني. قد لا يكون لديك ما يكفي من أنواع معينة من خلايا الدم البيضاء (قلة العدلات/ندرة المحببات) الذي قد يؤدي إلى زيادة خطر التعرض لعدوى أو حمى.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في الصدر، ذبحة صدرية، ضيق الصدر، ضيق التنفس، أزيز أو صعوبات في التنفس، ضربات قلب غير منتظمة أو قوية (خفقان).</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اصفرار الجلد أو العينين (اليرقان) مما قد يكون مؤشرًا على وجود التهاب في الكبد (التهاب الكبد الوبائي).</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">تم الإبلاغ عن الآثار الجانبية التالية أيضًا في المرضى المصابين بضغط الدم المرتفع والذين يتلقون العلاج بأكيوزايد:</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>الآثار الجانبية الشائعة: قد تصيب ما يصل إلى شخص واحد من بين كل 10 أشخاص</strong></p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإسهال، عسر الهضم، ألم خفيف في المعدة، الشعور بالغثيان أو القيء</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الدوار أو الصداع أو الشعور بالضعف أو الإرهاق أو النعاس أو الأرق</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في العضلات، ضعف العضلات، ألم الظهر</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مستويات مرتفعة من حمض اليوريك في دمك مما يتسبب في تورم المفاصل وألم المفاصل (النقرس)</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; السعال، الالتهاب الشعبي</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى الأنف أو الحلق، و/أو احتقان الأنف، و/أو رشح الأنف (التهاب الأنف)</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; توسع الأوعية الدموية</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في الصدر</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الحلق</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع مستويات الكرياتينين في مصل الدم. والكرياتينين هو جزيء يعتبر من المخلفات الناتجة عن أيض العضلات</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة مستويات النيتروجين في الدم، الذي يأتي من اليوريا وهي أحد مخلفات الجسم</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة تركيزات البوتاسيوم في الدم</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإحساس بضربات القلب</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة معدل ضربات القلب</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>آثار جانبية غير شائعة: قد تصيب ما يصل إلى شخص واحد من بين كل 100 شخص</strong></p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشكلات الكلى والمسالك البولية، عدوى مجرى البول</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إحساس بالخدر أو التنميل في الأطراف</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وجع المفاصل</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الاكتئاب والعصبية والارتباك</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طنين أو ضجيج في الأذنين</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ريح البطن</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتخاء العينين</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بأن الأشياء تدور أو تلف من حولك (الدوخة)</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإغماء، ضغط الدم المنخفض</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جفاف الفم أو الحلق أو اضطرابات حاسة التذوق</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احتباس السوائل في الجسم</p><ul><li style="direction: rtl;">الوذمة الوعائية (تورم الوجه أو اللسان أو الحلق، مما يسبب صعوبة التنفس)</li></ul><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الجيوب الأنفية</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالحرارة (الحمى)، زيادة العرق</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الشعر، الحكة، حساسية الجلد تجاه الضوء</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإخفاق في/عدم القدرة على الانتصاب</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى فيروسية</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق التنفس</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صورة خفيفة من داء السكري</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وجود بروتين في البول</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سكتة دماغية صغرى</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبة قلبية</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>آثار جانبية نادرة: قد تصيب ما يصل إلى شخص واحد من بين كل 1000 شخص</strong></p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشكلات في الاتزان</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الرئتين مما قد يسبب عدم القدرة على التنفس والسعال وارتفاع درجة الحرارة</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإمساك</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب اللسان</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الأوعية الدموية</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بثور الجلد</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصدفية</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات الجلد المرتبطة بالحمى وألم العضلات والمفاصل</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>آثار جانبية نادرة جدًا: قد تصيب ما يصل إلى شخص واحد من بين كل 10000 شخص</strong></p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انسداد الجهاز الهضمي (الأمعاء) أو التورم أو تجمع سوائل في الأمعاء الدقيقة</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيم الرؤية</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشرى</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>غير معروف: </strong>لا يمكن إثبات معدل التكرار من البيانات المتاحة</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حالة حساسية قد تؤدي إلى مشكلات في المفاصل والجلد والأعضاء (الذئبة الحمراء &quot;سيستمك لوباس ايريثماتوزيس&quot;)</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغير لون الجلد</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحكة وتقشر الجلد</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تقشر الجلد وآفات الجلد</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تضرر أنسجة الجلد</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في عدد خلايا الدم البيضاء أو انخفاض عدد الصفائح الدموية، مما قد يؤدي إلى التكدم أو حدوث نزيف بسهولة، انخفاض أعداد خلايا الدم الحمراء (فقر الدم)</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نزيف أو انسداد الأوعية الدموية في المخ (سكتة دماغية)</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تضيق المجاري الهوائية في الرئتين (التشنج القصبي)</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آثار تظهر في نتائج اختبارات الدم أو الاختبارات المعملية الأخرى</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة أعداد خلايا الدم المشاركة في أمراض الحساسية</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعل حساسية خطير</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الكبد</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اصفرار لون البشرة أو العينين</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب البنكرياس</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حالة تصيب الجهاز المناعي تؤثر على الجلد والأغشية المخاطية</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الكليتين</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب بطانة الرئتين أو القلب أو البطن</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضربات القلب غير المنتظمة</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض ضغط الدم عند الوقوف</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قصر النظر</p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زرق العين منغلق الزاوية الحاد (زيادة الضغط داخل العينين)</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">قد يسبب أكيوزايد بعض التغيرات في دمك وقد يجري طبيبك فحوصات دم من أجل مراقبة ذلك. إذا لاحظت إصابتك بتكدم أو شعورك بالتعب الشديد أو إذا كنت تعاني من داء السكري ولاحظت حدوث تغيرات في مستويات السكر لديك، فأخبر طبيبك حتى يمكن الترتيب لإجراء فحوصات دم إذا لزم الأمر.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>الإبلاغ عن الآثار الجانبية</strong></p><p style="direction: rtl;">إذا أصبت بأي آثار جانبية، فتحدث إلى طبيبك أو الصيدلي. يتضمن هذا أي آثار جانبية محتملة غير مدرجة في هذه النشرة. يمكنك أيضًا الإبلاغ عن الآثار الجانبية مباشرة عبر نظام الإبلاغ القومي المدرج في نهاية نشرة معلومات المريض هذه. بالإبلاغ عن الآثار الجانبية، يمكنك المساعدة في توفير المزيد من المعلومات حول سلامة هذا الدواء.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><u>نظام الإبلاغ القومي</u>:</p><p style="direction: rtl;">&nbsp;</p><table border="0" cellspacing="0" cellpadding="0" style="direction:rtl"><tbody><tr><td style="vertical-align:top"><p>المركز الوطني للتيقظ والسلامة الدوائية ( NPC )</p><p>&middot;&nbsp;&nbsp;&nbsp; فاكس: &lrm;+966 11 205 7662</p><p>&middot;&nbsp;&nbsp;&nbsp; &bull; للاتصال بالمركز الوطني للتيقظ والسلامة الدوائية على الرقم:&lrm; 00966 11 2038222، تحويلة:&lrm;<br />2317-2356-2340</p><p>&middot;&nbsp;&nbsp;&nbsp; الهاتف المجاني: 19999</p><p>&middot;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p>&middot;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://ade.sfda.gov.sa/</p><p>&nbsp;</p></td></tr></tbody></table><p style="direction: rtl;">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;">احفظ هذا الدواء بعيدًا عن مرأى ومتناول الأطفال.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">لا تستخدم أكيوزايد بعد تاريخ انتهاء الصلاحية المُدون على العبوة الكرتونية وشرائط البليستر بعد الرمز &quot;EXP&quot;. يشير تاريخ انتهاء الصلاحية إلى آخر يوم في ذلك الشهر.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">صلاحية المستحضر : سنتان .</p><p style="direction: rtl;">يتم التخزين في درجة حرارة أقل من 25 درجة مئوية. يُخزن في عبوته الأصلية.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">لا تتخلص من أي أدوية عبر مياه الصرف أو مع المخلفات المنزلية. اسأل الصيدلي الذي تتعامل معه عن كيفية التخلص من الأدوية التي لم تعد تستخدمها. ستساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">المادتان الفعالتان في أكيوزايد هما كوينابريل وهيدروكلوروثيازايد. يحتوي كل قرص على 20 ملجم من كوينابريل (في صورة 21.70 ملجم هيدروكلوريد كوينابريل) و12.5 ملجم هيدروكلوروثيازايد.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">تحتوي الأقراص أيضًا على مكونات غير فعالة: كربونات المغنيسيوم، ولاكتوز أحادي الهيدرات، وبوفيدون، وكروس بوفيدون، وستيارات المغنيسيوم.</p><p style="direction: rtl;">تحتوي أغلفة الأقراص على شمع الفربيون، وصبغة أوبادري وردية اللون OY-S-6937 التي تحتوي على أكسيد الحديد (E172)، وثاني أكسيد التيتانيوم (E171)، وهيدروكسي بروبيل ميثيل سليولوز، وهيدروكسي بروبيل سليولوز، وبولي إيثيلين جليكول.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            أقراص أكيوزايد هي أقراص مغلفة بطبقة رقيقة بيضاوية الشكل وردية اللون، بها حز على كلا الجانبين. 

تتوافر الأقراص في عبوات كرتونية تحتوي على30  قرصًا. 

        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;"><strong>مالك تصريح التسويق </strong>&nbsp;</p><p style="direction: rtl;">Pfizer Pharma PFE GmbH, Berlin, Germany</p><p style="direction: rtl;"><strong>&nbsp;</strong></p><p style="direction: rtl;"><strong>تم التصنيع</strong><strong> والتعبئة والتوزيع بواسطة</strong></p><p style="direction: rtl;">Pfizer Manufacturing Deutschland GmbH</p><p style="direction: rtl;">Betriebsst&auml;tte Freiburg</p><p style="direction: rtl;">Mooswaldallee 1</p><p style="direction: rtl;">79090 Freiburg</p><p style="direction: rtl;">Germany، ألمانيا</p><p style="direction: rtl;">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت آخر مراجعة لهذه النشرة في: مارس/آذار 2018.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Accuzide 20 mg/12.5 mg Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet contains quinapril 20 mg (as 21.664 mg quinapril hydrochloride) and
hydrochlorothiazide 12.5 mg. 

Excipients with known effect:
lactose monohydrate, 77.196 mg per tablet.

For the full list of excipients, see section 6.1.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablet.

Pink, triangular, biconvex, film-coated tablets with a scoreline on one side and plain on the reverse. The scoreline is only to facilitate breaking for ease of swallowing and not to divide into equal doses.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For the treatment of all grades of essential hypertension in patients who have been stabilised on the individual components given in the same proportions (see sections 4.3, 4.4, 4.5 and 5.1).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u></p><p>&nbsp;</p><p><em>Adults</em></p><p>For patients not currently receiving a diuretic, whether or not they have been receiving quinapril monotherapy, the recommended initial dosage of quinapril/hydrochlorothiazide is 10/12.5 mg. Following initial therapy, the dose may be increased to 20/12.5 mg. Effective blood pressure control is usually achieved with a dosage of 10/12.5 mg to 20/12.5 mg (see sections 4.3, 4.4, 4.5 and 5.1).</p><p>&nbsp;</p><p>The rate of quinapril absorption was reduced by 14% when Accuzide tablets were administered with a high fat meal as compared to fasting, while the extent of absorption was not affected. The rate of hydrochlorothiazide absorption was reduced by 12% when Accuzide tablets were administered with a high fat meal, while the extent of absorption was not significantly affected. Therefore, Accuzide may be administered without regard to food. The dose should always be taken at about the same time of day to increase compliance.</p><p>&nbsp;</p><p>In patients with congestive heart failure, with or without associated renal insufficiency, ACE inhibitor therapy for hypertension may cause an excessive drop in blood pressure.</p><p>&nbsp;</p><p>Accuzide therapy should be started under close medical supervision. Patients should be followed closely for the first two weeks of treatment and whenever the dosage is increased.</p><p><strong>&nbsp;</strong></p><p><em>Renal Impairment</em></p><p><strong>&nbsp;</strong></p><p>Accuzide is not recommended for use in patients with creatinine clearance of less than 40 mL/min.</p><p>&nbsp;</p><p><em>Elderly</em></p><p>The dose should be kept as low as possible commensurate with achievement of adequate blood pressure control.</p><p><strong>&nbsp;</strong></p><p><em>Paediatric Population</em></p><p>Currently available data are described in sections 5.1 and 5.2 but no recommendation on a posology can be made.</p><p>&nbsp;</p><p><u>Method of administration</u></p><p>&nbsp;</p><p>For oral use.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Accuzide is contraindicated:

•	In patients with hereditary/idiopathic angioneurotic oedema.

•	In patients with hypersensitivity to any of the active substances or to any of the excipients listed in section 6.1 or any other sulfonamide-derived drugs including patients with a history of angioedema related to previous treatment with angiotensin-converting enzyme (ACE) inhibitors.

•	In second and third trimesters of pregnancy (see sections 4.4 and 4.6). 

•	In patients with dynamic left ventricular outflow obstruction.

•	In patients with anuria, hyperkalaemia, or severe renal dysfunction. 

•	With administration of aliskiren-containing products in patients with diabetes mellitus or in patients with renal impairment (glomerular filtration rate [GFR] < 60 mL/ min/ 1.73 m2) (see sections 4.5 and 5.1). 

•	In combination with sacubitril/valsartan due to the increased risk of angioedema.	

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Aortic Stenosis</em></p><p>Accuzide should be used with caution in selected patients with aortic stenosis.</p><p><strong>&nbsp;</strong></p><p><em>Sensitivity Reactions</em></p><p>Sensitivity reactions may occur in patients with or without a history of allergy or bronchial asthma, e.g. purpura, photosensitivity, urticaria, necrotising angiitis, respiratory distress including pneumonitis, pulmonary oedema and anaphylactic reactions.</p><p><strong><em><u>&nbsp;</u></em></strong></p><p><em>Hypotension</em></p><p>Accuzide can cause symptomatic hypotension, usually not more frequently than either drug as monotherapy. Symptomatic hypotension was rarely seen in uncomplicated hypertensive patients. In hypertensive patients receiving quinapril, hypotension is more likely to occur if the patient has been volume-depleted e.g. by diuretic therapy, dietary salt restriction, dialysis, diarrhoea or vomiting, or has severe renin-dependent hypertension (see section 4.5).</p><p>&nbsp;</p><p>Accuzide should be used cautiously in patients receiving concomitant therapy with other antihypertensive agents. The thiazide component of Accuzide may potentiate the action of other hypertensive drugs, especially ganglionic or peripheral adrenergic-blocking drugs. The antihypertensive effects of the thiazide component may also be enhanced in postsympathectomized patients.</p><p>&nbsp;</p><p>If symptomatic hypotension occurs, the patient should be placed in the supine position and, if necessary, receive an intravenous infusion of normal saline. A transient hypotensive response is not a contraindication to further doses; however, lower doses of quinapril or of any concomitant diuretic therapy should be considered if this event occurs.</p><p>&nbsp;</p><p>In patients with congestive heart failure, with or without associated renal insufficiency, ACE inhibitor therapy for hypertension may cause an excessive drop in blood pressure, which may be associated with oliguria, azotemia, and in rare instances, with acute renal failure and death in such patients. Accuzide therapy should be started under close medical supervision. Patients should be followed closely for the first two weeks of treatment and whenever the dosage is increased.</p><p>&nbsp;</p><p><em>Heart Failure/Heart Disease</em></p><p>As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals. In patients with severe heart failure, whose renal function may depend on the activity of the renin-angiotensin-aldosterone system, treatment with quinapril, may be associated with oliguria and/or progressive azotemia and rarely acute renal failure and/or death.</p><p>&nbsp;</p><p><em>Cough</em></p><p>Cough has been reported with the use of ACE inhibitors, including quinapril. Characteristically, the cough is non-productive, persistent and resolves after discontinuation of therapy. ACE inhibitor-induced cough should be considered as part of the differential diagnosis of cough.</p><p>&nbsp;</p><p><em>Renal Disease</em></p><p>Accuzide should be used in caution in patients with severe renal disease. In severe renal disease thiazides may precipitate azotemia and in moderate renal impairment (creatinine clearance 10-20 mL/min) thiazides are generally ineffective in such patients, and the effects of repeated dosing may be cumulative.</p><p>&nbsp;</p><p>There is insufficient experience in patients with severe renal impairment (creatinine clearance &lt;10 mL/min). Before ACE inhibitor treatment, renal artery stenosis should be excluded in renal transplant patients.</p><p>&nbsp;</p><p>The half-life of quinapril is prolonged as creatinine clearance falls. Patients with a creatinine clearance of &lt;60 mL/min require a lower initial dosage of quinapril (see section 4.2). These patients&rsquo; dosage should be titrated upwards based upon therapeutic response, and renal function should be closely monitored although initial studies do not indicate that quinapril produces further deterioration in renal function.</p><p>&nbsp;</p><p>In clinical studies in hypertensive patients with unilateral or bilateral renal artery stenosis, increases in blood urea nitrogen and serum creatinine have been observed in some patients following ACE inhibition therapy. These increases were almost always reversible upon discontinuation of the ACE inhibitor and/or diuretic therapy. In such patients, renal function should be monitored during the first few weeks of therapy.</p><p>&nbsp;</p><p>Some patients with hypertension or heart failure with no apparent pre-existing renal vascular disease have developed increases (&gt;1.25 times the upper limit of normal) in blood urea nitrogen and serum creatinine, usually minor and transient, especially when quinapril has been given concomitantly with a diuretic.<u> </u>Increases in blood urea nitrogen and serum creatinine have been observed in 2% and 2%, respectively of hypertensive patients on quinapril monotherapy and in 4% and 3%, respectively of hypertensive patients on quinapril/hydrochlorothiazide. These&nbsp; increases are more likely to occur in patients with pre-existing renal impairment. Dosage reduction and/or discontinuation of any diuretic and/or quinapril may be required.</p><p>&nbsp;</p><p><em>Dual Blockade of the Renin-Angiotensin-Aldosterone System (RAAS)</em></p><p>There is evidence that the concomitant use of ACE inhibitors, angiotensin II receptor blockers or aliskiren increases the risk of hypotension, hyperkalaemia and decreased renal function (including acute renal failure). Dual blockade of RAAS through the combined use of ACE inhibitors, angiotensin II receptor blockers or aliskiren is therefore not recommended (see sections 4.5 and 5.1).</p><p>If dual blockade therapy is considered absolutely necessary, this should only occur under specialist supervision and subject to frequent close monitoring of renal function, electrolytes and blood pressure.</p><p>ACE inhibitors and angiotensin II receptor blockers should not be used concomitantly in patients with diabetic nephropathy.</p><p>&nbsp;</p><p><em>Impaired Hepatic Function</em></p><p>Accuzide should be used with caution in patients with impaired hepatic function or progressive liver disease since minor alterations of fluid and electrolyte balance may result from thiazide treatment and may precipitate hepatic coma. Quinapril is rapidly deesterified to quinaprilat, (quinapril diacid, the principal metabolite), which, in human and animal studies, is a potent ACE inhibitor. The metabolism of quinapril is normally dependent upon hepatic esterase. Quinaprilat concentrations are reduced in patients with alcoholic cirrhosis due to impaired deesterification of quinapril.</p><p>&nbsp;</p><p>Rarely, ACE inhibitors have been associated with a syndrome beginning as a cholestatic jaundice and progressing to a fulminant hepatic necrosis (in some cases fatal). Patients who during ACE inhibitor therapy experience jaundice or clearly elevated hepatic enzymes should discontinue Accuzide and receive appropriate medical follow-up.</p><p>&nbsp;</p><p><em>Immune-Mediated Drug Reactions/Anaphylactoid Reactions</em></p><p>Desensitisation: Patients receiving ACE inhibitors during desensitising treatment with hymenoptera venom have sustained life-threatening anaphylactoid reactions. In the same patients, these reactions have been avoided when ACE inhibitors were temporarily withheld, but they have reappeared upon inadvertent challenge.</p><p>&nbsp;</p><p>Stevens-Johnson syndrome and exacerbations or activation of systemic lupus erythematosus have been reported with thiazides.</p><p>&nbsp;</p><p><em>Angioedema</em></p><p>Angioedema has been reported in patients treated with ACE inhibitors. If laryngeal stridor or angioedema of the face, tongue, or glottis occur, treatment should be discontinued immediately, the patient treated appropriately in accordance with accepted medical care, and carefully observed until the swelling disappears. In instances where swelling is confined to the face and lips, the condition generally resolves without treatment; antihistamines may be useful in relieving symptoms. Angioedema associated with laryngeal involvement may be fatal. Where there is involvement of the tongue, glottis, or larynx likely to cause airway obstruction, appropriate therapy e.g., subcutaneous adrenaline solution 1:1000 (0.3 - 0.5 mL) should be promptly administered.</p><p>&nbsp;</p><p>The combination of quinapril with sacubitril/valsartan is contraindicated due to the increased risk of angioedema (see section 4.3). Sacubitril/valsartan must not be initiated until 36 hours after taking the last dose of quinapril therapy. If treatment with sacubitril/valsartan is stopped, quinapril therapy must not be initiated until 36 hours after the last dose of sacubitril/valsartan (see sections 4.3 and 4.5). Concomitant use of other NEP inhibitors (e.g. racecadotril) and ACE inhibitors may also increase the risk of angioedema (see section 4.5). Hence, a careful benefit-risk assessment is needed before initiating treatment with NEP inhibitors (e.g. racecadotril) in patients on quinapril.</p><p><strong><u>&nbsp;</u></strong></p><p>Patients taking a concomitant mammalian target of rapamycin (mTOR) inhibitor (e.g. temsirolimus) or a concomitant dipeptidyl peptidase-IV (DPP-IV) inhibitor (e.g. vildagliptin) therapy may be at an increased risk for angioedema. Caution should be used when starting an mTOR inhibitor or a DPP-IV inhibitor in a patient already taking an ACE inhibitor (see section 4.5).</p><p>&nbsp;</p><p>Patients with a history of angioedema unrelated to ACE inhibitor therapy may be at an increased risk of angioedema while receiving an ACE inhibitor (see also section 4.3).</p><p>&nbsp;</p><p>Other hypersensitivity reactions have been reported.</p><p>&nbsp;</p><p><em>Intestinal Angioedema</em></p><p>Intestinal angioedema has been reported in patients treated with ACE inhibitors. These patients presented with abdominal pain (with or without nausea or vomiting); in some cases there was no prior history of facial angioedema and C-1 esterase levels were normal. The angioedema was diagnosed by procedures including abdominal CT scan or ultrasound, or at surgery, and symptoms resolved after stopping the ACE inhibitor. Intestinal angioedema should be included in the differential diagnosis of patients on ACE inhibitors presenting with abdominal pain.</p><p>&nbsp;</p><p><em>Ethnic Differences</em></p><p>Black patients receiving ACE inhibitor therapy have been reported to have a higher incidence of angioedema compared to non-black patients. It should also be noted that in controlled clinical trials, ACE inhibitors have an effect on blood pressure that is less in black patients than in non-black patients.</p><p><em>&nbsp;</em></p><p><em>Haemodialysis and Low-Density Lipoprotein Apheresis</em></p><p>Patients haemodialysed using high-flux polyacrylonitrile (&#39;AN69&#39;) membranes are highly likely to experience anaphylactoid reactions if they are treated with ACE inhibitors. This combination should therefore be avoided, either by use of alternative antihypertensive drugs or alternative membranes for haemodialysis. Similar reactions have been observed during low density lipoprotein apheresis with dextran-sulfate. This method should therefore not be used in patients treated with ACE inhibitors.</p><p>&nbsp;</p><p><em>Derangements of Serum Electrolytes</em></p><p>Patients receiving Accuzide should be observed for clinical signs of thiazide induced fluid or electrolyte imbalance. In such patients periodic determination of serum electrolytes (sodium and potassium in particular) should be performed. Because quinapril reduces the production of aldosterone, its combination with &nbsp;hydrochlorothiazide may minimise diuretic induced hypokalaemia.</p><p>&nbsp;</p><p>The opposite effects of quinapril and &nbsp;hydrochlorothiazide on serum potassium will approximately balance each other in many patients so that no net effect upon serum potassium will be seen. In other patients, one or the other effect may be dominant and some patients may still require potassium supplements. Initial and periodic determinations of serum electrolytes to detect possible electrolyte imbalance should be performed at appropriate intervals.</p><p>&nbsp;</p><p>Calcium excretion is decreased by thiazides. In a few patients on prolonged thiazide therapy, pathological changes in the parathyroid gland have been observed, with hypercalcemia and hypophosphatemia. More serious complications of hyperparathyroidism (renal lithiasis, bone resorption, and peptic ulceration) have not been seen.</p><p>&nbsp;</p><p>Thiazides should be discontinued before performing tests for parathyroid function.</p><p>&nbsp;</p><p>Thiazides increase the urinary excretion of magnesium, and hypomagnesemia may result (see section 4.5).</p><p>&nbsp;</p><p><em>Other Metabolic Disturbances</em></p><p>Thiazide diuretics tend to reduce glucose tolerance and raise serum levels of cholesterol, triglycerides, and uric acid. These effects are usually minor, but frank gout or overt diabetes may be precipitated in susceptible patients.</p><p>&nbsp;</p><p><em>Hypokalaemia</em></p><p>Conversely, treatment with thiazide diuretics has been associated with hypokalaemia, hyponatremia, and hypochloremic alkalosis. These disturbances have sometimes been manifest as one or more of the following: dryness of mouth, thirst, weakness, lethargy, drowsiness, restlessness, muscle pains or cramps, muscular fatigue, hypotension, oliguria, tachycardia, nausea, confusion, seizures and vomiting. Hypokalaemia can also sensitize or exaggerate the response of the heart to the toxic effects of digitalis. The risk of hypokalaemia is greatest in patients with cirrhosis of the liver, in patients experiencing a brisk diuresis, in patients who are receiving inadequate oral intake of electrolytes, and in patients receiving concomitant therapy with corticosteroids or adrenocorticotrophic hormone (ACTH) or with other drugs known to increase the risk of hypokalaemia induced by thiazide diuretics.</p><p>&nbsp;</p><p><em>Hyperkalaemia </em></p><p>Concomitant medications that could raise serum potassium levels should be carefully considered. Patients should be told not to use potassium supplements or salt substitutes containing potassium without consulting their physician (see section 4.5).</p><p><em>&nbsp;</em></p><p><em>Diabetes</em></p><p>Thiazide-induced hyperglycaemia may compromise blood sugar control. Depletion of serum potassium augments glucose intolerance. Monitor glycaemic control, supplement potassium, if necessary, to maintain appropriate serum potassium levels, and adjust diabetes medications as required (see section 4.5).<sup> </sup></p><p><strong><em><u>&nbsp;</u></em></strong></p><p>In diabetic patients ACE inhibitors may enhance insulin sensitivity and have been associated with hypoglycaemia in patients treated with oral antidiabetic agents or insulin. Glycaemic control should be closely monitored particularly during the first month of treatment with an ACE inhibitor (see section 4.5).</p><p>&nbsp;</p><p><em>Hyperuricaemia and Gout&nbsp; </em></p><p>Thiazide diuretics tend to raise serum levels of uric acid and may precipitate gout in certain patients.</p><p><strong><em><u>&nbsp;</u></em></strong></p><p><em>Neutropenia/Agranulocytosis</em></p><p>ACE inhibitors have been rarely associated with agranulocytosis and bone marrow depression in patients with uncomplicated hypertension, but more frequently in patients with renal impairment, especially if they also have a connective disease with the concomitant use of immunosuppressive or other agents which may be associated with neutropenia/agranulocytosis. Patients should be told to report promptly any indication of infection (e.g., sore throat, fever) as this could be a sign of neutropenia (see section 4.5).</p><p>&nbsp;</p><p>Agranulocytosis has been rarely reported during treatment with quinapril. As with other ACE inhibitors, monitoring of white blood cell counts in patients with collagen vascular disease and/or renal disease should be considered.</p><p>&nbsp;</p><p>The preparation should be used with particular care in elderly patients, or those with potential obstruction of the urinary tract, or with disorders rendering their electrolyte balance precarious or those with impaired hepatic or renal function.</p><p>&nbsp;</p><p><em>Surgery/Anaesthesia</em></p><p>In patients undergoing major surgery or during anaesthesia with agents that produce hypotension, quinapril may block angiotensin II formation secondary to compensatory renin release. If hypotension occurs and is considered to be due to this mechanism, it can be corrected by volume expansion.</p><p>&nbsp;</p><p><em>Acute Myopia and Secondary Angle-Closure Glaucoma</em></p><p>Hydrochlorothiazide, a sulfonamide, can cause an idiosyncratic reaction, resulting in acute transient myopia and acute angle-closure glaucoma. Symptoms include acute onset of decreased visual acuity or ocular pain and typically occur within hours to weeks of drug initiation. Untreated acute angle-closure glaucoma can lead to permanent vision loss. The primary treatment is to discontinue hydrochlorothiazide as rapidly as possible. Prompt medical or surgical treatments may need to be considered if the intraocular pressure remains uncontrolled. Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy.</p><p>&nbsp;</p><p><em>Pregnancy</em></p><p>ACE inhibitors should not be initiated during pregnancy. Unless continued ACE inhibitor therapy is considered essential, patients planning pregnancy should be changed to alternative antihypertensive treatments which have an established safety profile for use in pregnancy. When pregnancy is diagnosed, treatment with ACE inhibitors should be stopped immediately, and, if appropriate, alternative therapy should be started (see sections 4.3 and 4.6).</p><p>When pregnancy is detected, discontinue Accuzide as soon as possible.</p><p>Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.</p><p>&nbsp;</p><p><em>Lactose</em></p><p>Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose/galactose malabsorption should not use this medicine.</p><p>&nbsp;</p><p><em>Lithium</em></p><p>Lithium generally should not be given with diuretics. Diuretic agents reduce the renal clearance of lithium and add a high risk of lithium toxicity (see section 4.5).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Tetracycline and Other Drugs That Interact with Magnesium </em></p><p>Because of the presence of magnesium carbonate in the formulation, quinapril has been shown in healthy volunteers to reduce the absorption of tetracycline in concomitant administration by 28 to 37%. It is recommended that concomitant administration of Accuzide with tetracycline be avoided. This interaction should be considered if coprescribing quinapril and tetracycline.</p><p>&nbsp;</p><p><em>Agents Increasing Serum Potassium</em></p><p>Accuzide contains a thiazide diuretic, which tends to increase the urinary excretion of potassium but it also contains an ACE inhibitor, which tends to conserve potassium by lowering aldosterone levels. It is not advisable to routinely add potassium sparing diuretics, &nbsp;potassium supplements, or other drugs known to raise serum potassium levels as this may result in elevated serum potassium.</p><p>&nbsp;</p><p><em>Trimethoprim/Sulfamethoxazole</em></p><p>Both trimethoprim/sulfamethoxazole and quinapril are known to cause hyperkalaemia. Therefore, care must be taken when these agents are administered together, and appropriate monitoring of serum potassium levels is recommended. Patients at particular risk of hyperkalaemia induced by co-administration of trimethoprim/sulfamethoxazole and ACE inhibitors include elderly patients and patients with renal impairment.</p><p>&nbsp;</p><p><em>Other Diuretics</em></p><p>Accuzide contains a diuretic. Concomitant use of another diuretic may have an additive effect. Also, patients on diuretics, especially those who are volume and/or salt depleted, may experience an excessive reduction of blood pressure on initiation of therapy, or with increased dosage of an ACE inhibitor.</p><p><em>&nbsp;</em></p><p><em>Other Antihypertensive Drugs</em></p><p>There may be an additive effect or potentiation when Accuzide is combined with other antihypertensive drugs such as nitrates or vasodilators.</p><p>&nbsp;</p><p><em>Surgery/Anaesthesia</em></p><p>Although no data are available to indicate that there is an interaction between quinapril and anaesthetic agents that produce hypotension, caution should be exercised when patients undergo major surgery or anaesthesia since ACE inhibitors have been shown to block angiotensin II formation secondary to compensatory renin release. This may lead to hypotension which can be corrected by volume expansion. (see section 4.4).</p><p>&nbsp;</p><p>Thiazides may decrease the arterial response to noradrenaline. In emergency surgery pre-anaesthetic and anaesthetic agents should be administered in reduced doses.</p><p>Thiazides may increase the response to tubocurarine.&nbsp;</p><p>&nbsp;</p><p><em>Lithium</em></p><p>Lithium generally should not be given with diuretics. Diuretic agents reduce the renal clearance of lithium and add a high risk of lithium toxicity. Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy due to the sodium-losing effect of these agents. With Accuzide, the risk of lithium toxicity may be increased. Accuzide should be administered with caution and frequent monitoring of serum lithium levels is recommended.</p><p>&nbsp;</p><p><em>Corticosteroids, ACTH</em></p><p>Intensified electrolyte depletion, particularly hypokalaemia has been observed.</p><p>&nbsp;</p><p><em>Non-Steroidal Anti-Inflammatory Drugs</em></p><p>Non-steroidal anti-inflammatory agents including selective (NSAID) cyclooxygenase-2 inhibitors (COX-2 inhibitors): In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective cyclooxygenase-2&nbsp; (COX-2) inhibitors, with ACE inhibitors, including quinapril, may result in deterioration of renal function, including possible acute renal failure. These effects are usually reversible. Monitor renal function periodically in patients receiving quinapril and NSAID therapy.</p><p>The antihypertensive effect of ACE inhibitors, including quinapril may be attenuated by NSAIDs.</p><p>&nbsp;</p><p><em>Other drugs known to cause Angioedema </em></p><p>Patients taking a concomitant mTOR inhibitor (e.g. temsirolimus) or a concomitant DPP-IV inhibitor (e.g. vildagliptin) therapy may be at an increased risk for angioedema. Caution should be used when starting an mTOR inhibitor or a DPP-IV inhibitor in a patient already taking an ACE inhibitor (see section 4.4).</p><p>&nbsp;</p><p><em>NEP Inhibitors </em></p><p>The concomitant use of quinapril with sacubitril/valsartan is contraindicated, as the concomitant inhibition of neprilysin (NEP) and ACE may increase the risk of angioedema. Sacubitril/valsartan must not be started until 36 hours after taking the last dose of quinapril therapy. Quinapril therapy must not be started until 36 hours after the last dose of sacubitril/valsartan (see sections 4.3 and 4.4). Concomitant use of other NEP inhibitors (e.g. racecadotril) and quinapril may also increase the risk of angioedema (see section 4.4).</p><p><strong><em>&nbsp;</em></strong></p><p><em>Allopurinol, Cytostatic and Immunosuppressive Agents, Systemic Corticosteroids or Procainamide </em></p><p>Concomitant administration with ACE inhibitors may lead to an increased risk for leucopoenia.</p><p>&nbsp;</p><p><em>Alcohol, Barbiturates or Narcotics</em></p><p>Potentiation of orthostatic hypotension may occur.</p><p><strong><em>&nbsp;</em></strong></p><p><em>Drugs associated with Torsades de Pointes</em></p><p>Due to the potential risk of hypokalaemia, caution should be used when hydrochlorothiazide is co-administered with medicines such as digitalis glycosides or agents associated with torsades de pointes (e.g. amiodarone, sotalol).</p><p><strong><em>&nbsp;</em></strong></p><p><em>Antacids</em></p><p>Antacids may decrease the bioavailability of Accuzide.</p><p>&nbsp;</p><p><em>Antidiabetic drugs (Oral Hypoglycaemic Agents and Insulin)</em></p><p>In diabetic patients ACE inhibitors may enhance insulin sensitivity and have been associated with hypoglycaemia in patients treated with oral antidiabetic agents or insulin. Glycaemic control should be closely monitored (see section 4.4).<em> </em>Dosage adjustments of antidiabetic drugs may be required when administered concomitantly with ACE inhibitors. This is more likely to be required during the first month of combined treatment and in patients with renal impairment.</p><p>&nbsp;</p><p>Thiazide-induced hyperglycaemia may compromise blood sugar control. Depletion of serum potassium augments glucose intolerance. Monitor glycaemic control, supplement potassium, if necessary, to maintain appropriate serum potassium levels, and adjust diabetes medications as required (see section 4.4).</p><p>&nbsp;</p><p><em>Pressor Amines (e.g., Norepinephrine)</em></p><p>Possible decreased response to pressor amines, but not sufficient to preclude their use.</p><p>&nbsp;</p><p><em>Anion Exchange Resins</em></p><p>Absorption of hydrochlorothiazide is impaired in the presence of anion exchange resins, such as cholestyramine and colestipol. Single doses of the resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.</p><p>&nbsp;</p><p><em>Dual Blockade of the Renin-Angiotensin-Aldosterone System (RAAS)</em></p><p>Clinical trial data has shown that dual blockade of the renin-angiotensin-aldosterone-system (RAAS) through the combined use of angiotensin II receptors blockers, ACE inhibitors or aliskiren is associated with a higher frequency of adverse events such as hypotension, hyperkalaemia, and decreased renal function (including acute renal failure) compared to the use of a single RAAS-acting agent (see sections 4.3, 4.4 and 5.1).</p><p><strong><em>&nbsp;</em></strong></p><p><em>Other Agents</em></p><p>No clinically important pharmacokinetic interactions occurred when quinapril was used concomitantly with propranolol, hydrochlorothiazide or cimetidine.&nbsp;</p><p><u>&nbsp;</u></p><p>The anticoagulant effect of a single dose of warfarin (measured by prothrombin time) was not significantly changed by quinapril co-administration twice daily.</p><p><strong><em>&nbsp;</em></strong></p><p><em>Digoxin</em></p><p>Thiazide-induced electrolyte disturbances, i.e. hypokalaemia, hypomagnesemia, increase the risk of digoxin toxicity, which may lead to fatal arrhythmic events (see section 4.4).</p><p><strong>&nbsp;</strong></p><p><em>Gout Medications (Allopurinol, Uricosurics, Xanthine Oxidase Inhibitors)</em></p><p>Thiazide-induced hyperuricemia may compromise control of gout by allopurinol and probenecid. The co-administration of hydrochlorothiazide and allopurinol may increase the incidence of hypersensitivity reactions to allopurinol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p><em>&nbsp;</em></p><p><em>ACE Inhibitors</em></p><p>The use of ACE inhibitors is not recommended during the first trimester of pregnancy (see section 4.4). The use of ACE inhibitors is contraindicated during the 2nd and 3rd trimester of pregnancy (see sections 4.3 and 4.4).</p><p>&nbsp;</p><p>Epidemiological evidence regarding the risk of teratogenicity following exposure to ACE inhibitors during the first trimester of pregnancy has not been conclusive; however a small increase in risk cannot be excluded. Unless continued ACE inhibitor therapy is considered essential, patients planning pregnancy should be changed to alternative antihypertensive treatments which have an established safety profile for use in pregnancy. When pregnancy is diagnosed, treatment with ACE inhibitors should be stopped immediately, and, if appropriate, alternative therapy should be started.</p><p>&nbsp;</p><p>Exposure to ACE inhibitor therapy during the second and third trimesters is known to induce human foetotoxicity (decreased renal function, oligohydramnios, skull ossification retardation) and neonatal toxicity (renal failure, hypotension, hyperkalaemia). (See section 5.3.). Should exposure to ACE inhibitor have occurred from the second trimester of pregnancy, ultrasound check of renal function and skull is recommended. Infants whose mothers have taken ACE inhibitors should be closely observed for hypotension (sections 4.3 and 4.4)</p><p>&nbsp;</p><p><em>Hydrochlorothiazide</em></p><p>There is limited experience with hydrochlorothiazide during pregnancy, especially during the first trimester. Animal studies are insufficient. Hydrochlorothiazide crosses the placenta Based on the pharmacological mechanism of action of hydrochlorothiazide its use during the second and third trimester may compromise foeto-placental perfusion and may cause foetal and neonatal effects like icterus, disturbance of electrolyte balance and thrombocytopenia.</p><p>Hydrochlorothiazide should not be used for gestational oedema, gestational hypertension or preeclampsia due to the risk of decreased plasma volume and placental hypoperfusion, without a beneficial effect on the course of the disease.</p><p>&nbsp;</p><p>Hydrochlorothiazide should not be used for essential hypertension in pregnant women except in rare situations where no other treatment could be used.</p><p>&nbsp;</p><p><u>Breast-feeding</u></p><p><em>&nbsp;</em></p><p><em>Quinapril</em></p><p>Limited pharmacokinetic data demonstrate very low concentrations in breast milk. Although these concentrations seem to be clinically irrelevant, the use of <strong>Accuzide</strong><strong> </strong>in breastfeeding is not recommended for preterm infants and for the first few weeks after delivery, because of the hypothetical risk of cardiovascular and renal effects and because there is not enough clinical experience.</p><p>&nbsp;</p><p>In the case of an older infant, the use of <strong>Accuzide</strong><strong> </strong>in a breast-feeding mother may be considered if this treatment is necessary for the mother and the child is observed for any adverse effect.</p><p>&nbsp;</p><p><em>Hydrochlorothiazide</em></p><p>Hydrochlorothiazide is excreted in human milk in small amounts. Thiazides in high doses causing intense diuresis can inhibit the milk production. The use of Accuzide during breast feeding is not recommended. If Accuzide is used during breast feeding doses should be kept as low as possible.&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The ability to engage in activities such as operating machinery or operating a motor vehicle may be impaired, especially when initiating Accuzide therapy.&nbsp; Patients should be stabilised on medication before driving.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following undesirable effects have been observed and reported during treatment with quinapril/hydrochlorothiazide with the following frequencies: very common (&ge;1/10); common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1,000 to &le;1/100); rare (&ge;1/10,000 to &le;1/1,000); very rare (&le;1/10,000), not known (cannot be estimated from the available data).</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td><td style="vertical-align:top"><p><strong>Undesirable effects</strong></p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong>&nbsp;</strong></p><p><strong>Infections and infestations</strong></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Bronchitis, upper respiratory tract infection, pharyngitis<sup>#</sup>, rhinitis<sup>#</sup>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Viral infection, urinary tract infection, sinusitis&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Blood and the lymphatic system disorders</strong></p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Agranulocytosis<sup>##</sup>, haemolytic anaemia<sup>#&infin;</sup>, neutropenia<sup>##</sup>, thrombocytopenia<sup>#</sup>, eosinophilia<sup>#</sup></p></td></tr><tr><td style="vertical-align:top"><p><strong>Immune system disorders</strong></p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Anaphylactoid reaction<sup>#</sup></p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong>Metabolism and nutrition disorders</strong></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Hyperkalaemia<sup>##</sup>, gout<sup>#</sup>, hyperuricemia<sup>#</sup></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Glucose tolerance impaired</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong>Psychiatric disorders</strong></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Insomnia<sup>#</sup></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Confusional state<sup>#</sup>, depression<sup>#</sup>, nervousness<sup>#</sup></p></td></tr><tr><td rowspan="4" style="vertical-align:top"><p><strong>Nervous system disorders</strong></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Dizziness<sup>#</sup>, headache<sup>#</sup>, somnolence<sup>#</sup></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Transient ischaemic attack<sup>#</sup>, syncope<sup>#, </sup>paraesthesia<sup>#</sup>, dysgeusia<sup>##</sup></p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Balance disorder</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Cerebrovascular accident<sup>#</sup></p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p><strong>Eye disorders</strong></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Amblyopia<sup>#</sup></p></td></tr><tr><td style="vertical-align:top"><p>Very Rare</p></td><td style="vertical-align:top"><p>Vision blurred<sup>#</sup></p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Acute myopia#, Acute angle closure glaucoma#</p></td></tr><tr><td style="vertical-align:top"><p><strong>Ear and labyrinth disorders</strong></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Vertigo<sup>#</sup>, tinnitus<sup>#</sup>,</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p><strong>Cardiac disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;Common</p></td><td style="vertical-align:top"><p>Angina pectoris<sup>##</sup>, tachycardia<sup>#</sup>, palpitations<sup># </sup></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Myocardial infarction<sup>#</sup></p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Arrhythmia</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p><strong>Vascular disorders</strong></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Vasodilation<sup>#</sup></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Hypotension<sup>#</sup></p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Orthostatic hypotension<sup>#</sup></p></td></tr><tr><td rowspan="4" style="vertical-align:top"><p><strong>Respiratory, thoracic and mediastinal disorders</strong></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Cough<sup>#</sup></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Dyspnoea<sup>#</sup>, dry throat</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Eosinophilic pneumonia<sup>##</sup>, upper airways obstruction by angioedema (that may be fatal)<sup>#</sup></p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Bronchospasm<sup>#</sup></p></td></tr><tr><td rowspan="5" style="vertical-align:top"><p><strong>Gastrointestinal disorders</strong></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Vomiting<sup>#</sup>, diarrhoea<sup>#</sup>, dyspepsia<sup>#</sup>, abdominal pain<sup>#</sup>, nausea<sup>#</sup></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Flatulence<sup>#</sup>, dry mouth</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Constipation, glossitis</p></td></tr><tr><td style="vertical-align:top"><p>Very Rare</p></td><td style="vertical-align:top"><p>Ileus<sup>#</sup>, small bowel angioedema</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Pancreatitis<sup>#</sup></p></td></tr><tr><td style="vertical-align:top"><p><strong>Hepatobiliary disorders</strong></p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Hepatitis<sup>#</sup>, jaundice cholestatic<sup>#</sup></p></td></tr><tr><td rowspan="4" style="vertical-align:top"><p><strong>Skin and subcutaneous tissue disorders</strong></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Alopecia<sup>#</sup>, photosensitivity reaction<sup>#</sup>, pruritus<sup>#</sup>, rash<sup>#</sup>, angioedema<sup>##</sup>, hyperhidrosis <sup>##</sup></p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Skin disorders may be associated with fever, muscle and joint pain (myalgias, arthralgias, arthritis), vascular inflammation (vasculitis), dermatitis psoriasis forms<sup>#</sup></p></td></tr><tr><td style="vertical-align:top"><p>Very Rare</p></td><td style="vertical-align:top"><p>Urticaria<sup>#</sup></p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Toxic epidermal necrolysis<sup>#</sup>, erythema multiforme<sup>#</sup>, dermatitis exfoliative<sup>#</sup>, pemphigus<sup>#</sup>, purpura, Stevens Johnson syndrome<sup>#</sup></p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p><strong>Musculoskeletal, connective tissue and bone disorders</strong></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Back pain<sup>#</sup>, myalgia<sup>#</sup></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Arthralgia<sup>#</sup></p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Systemic lupus erythematosus</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong>Renal and urinary disorders</strong></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Renal impairment<sup>#</sup>, proteinuria</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Tubulointerstitial nephritis</p></td></tr><tr><td style="vertical-align:top"><p><strong>Reproductive system and breast disorders</strong></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Erectile dysfunction <sup>#</sup></p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p><strong>General disorders and administration site conditions</strong></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Asthenia<sup>#</sup>, chest pain<sup>#</sup>, fatigue<sup>#</sup></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Generalised oedema<sup>#</sup>, pyrexia<sup> #</sup>, oedema peripheral<sup>#</sup></p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Serositis</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong>Investigations</strong></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Blood creatinine increased<sup>#</sup>, blood urea increased<sup>#</sup>*</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Blood cholesterol increased<sup>#</sup>, triglyceride increased<sup>#</sup>.</p><p>Haematocrit decreased<sup>#</sup>, hepatic enzyme increased, blood bilirubin increased, antinuclear antibody increased<sup>#</sup>, red blood cell sedimentation rate increased.</p></td></tr></tbody></table><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>* Such increases are more likely to occur in patients receiving concomitant diuretic therapy than those on monotherapy with quinapril. These observed increases will often reverse on continued therapy.</p><p>&nbsp;</p><p><sup>#</sup> Adverse reactions associated with quinapril component, frequencies observed when taking quinapril/hydrochlorothiazide.</p><p>&nbsp;</p><p><sup>##</sup> Adverse reactions associated with quinapril component, frequencies observed in quinapril, adverse reactions not associated with quinapril/hydrochlorothiazide component.</p><p>&nbsp;</p><p><sup>&infin;</sup> In patients with a congenital G-6-PDH deficiency, individual cases of haemolytic anaemia<sup>#</sup> have been reported.</p><p>&nbsp;</p><p>Other Clinical Laboratory Test Findings:</p><p><u>&nbsp;</u></p><p><u>Serum electrolytes</u> (see section 4.4)</p><p><u>&nbsp;</u></p><p><u>Serum uric acid </u>(see section 4.4)<u> </u></p><p><u>&nbsp;</u></p><p><u>Glucose </u>(see section 4.4)</p><p><u>&nbsp;</u></p><p><u>Changes in magnesium, PBI (Protein bound iodine), parathyroid function tests and calcium</u> (see section 4.4)</p><p>&nbsp;</p><p><u>Haematology test</u> (see section 4.4).</p><p><strong><u>&nbsp;</u></strong></p><p><strong><u>Reporting of suspected adverse reactions</u></strong></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>National Pharmacovigilance and Drug Safety Centre ( NPC )</p><ul><li>Fax: +966 11 205 7662</li></ul><ul><li>Call NPC at 00966 11 2038222, Exts: 2317-2356-2340</li><li>SFDA Call Center: 19999</li><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: https://ade.sfda.gov.sa/</li></ul><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No data are available for Accuzide with respect to overdosage in humans.&nbsp; The most likely clinical manifestation would be symptoms attributable to quinapril monotherapy overdosage such as severe hypotension, which would usually be treated by infusion of intravenous normal saline.</p><p>&nbsp;</p><p>The most common signs and symptoms observed for hydrochlorothiazide monotherapy overdosage are those caused by electrolyte depletion (hypokalaemia, hypochloraemia, hyponatremia) and dehydration resulting from excessive diuresis. If digitalis has also been administered, hypokalaemia may accentuate cardiac arrhythmias.</p><p>&nbsp;</p><p>No specific information is available on the treatment of overdosage with Accuzide.</p><p>&nbsp;</p><p>Haemodialysis and peritoneal dialysis have little effect on the elimination of quinapril and quinaprilat. Treatment is symptomatic and supportive consistent with established medical care.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: quinapril and diuretics, ATC code: C09BA06</p><p>&nbsp;</p><p>Quinapril is rapidly de-esterified to quinaprilat (quinapril diacid, the principal metabolite), which is a potent ACE inhibitor.</p><p>&nbsp;</p><p>Quinapril and hydrochlorothiazide lower blood pressure by different, though complementary mechanisms.&nbsp; With diuretic treatment, blood pressure and blood volume fall, resulting in a rise in angiotensin II levels which tend to blunt the hypotensive effect.&nbsp; Quinapril blocks this rise in angiotensin II.&nbsp; The antihypertensive effects of quinapril and hydrochlorothiazide are additive.</p><p>&nbsp;</p><p>In a randomized clinical trial using target doses of 2.5, 5, 10 and 20 mg of quinapril, in 112 children and adolescents with hypertension or high normal blood pressure over 8 weeks (2 weeks double blind and 6 weeks extension), failed to reach its primary objective of reduction of diastolic blood pressure after 2 weeks. For systolic blood pressure (secondary objective of efficacy) at Week 2 only there was a statistically significant linear dose response across treatments with a significant difference between the quinapril 20 mg QD and placebo treatment groups.</p><p>Long term effects of quinapril on growth, puberty and general development have not been studied.</p><p>&nbsp;</p><p>Two large randomised, controlled trials (ONTARGET (On-going Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) and VA NEPHRON-D (The Veterans Affairs Nephropathy in Diabetes)) have examined the use of the combination of an ACE inhibitor with an angiotensin II receptor blocker.</p><p>&nbsp;</p><p>ONTARGET was a study conducted in patients with a history of cardiovascular or cerebrovascular disease, or type 2 diabetes mellitus accompanied by evidence of end-organ damage. VA NEPHRON-D was a study in patients with type 2 diabetes mellitus and diabetic nephropathy.</p><p>&nbsp;</p><p>These studies have shown no significant beneficial effect on renal and/or cardiovascular outcomes and mortality, while an increased risk of hyperkalaemia, acute kidney injury and/or hypotension as compared to monotherapy was observed. Given their similar pharmacodynamic properties, these results are also relevant for other ACE inhibitors and angiotensin II receptor blockers.</p><p>&nbsp;</p><p>ACE inhibitors and angiotensin II receptor blockers should therefore not be used concomitantly in patients with diabetic nephropathy.</p><p>&nbsp;</p><p>ALTITUDE (Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints) was a study designed to test the benefit of adding aliskiren to a standard therapy of an ACE inhibitor or an angiotensin II receptor blocker in patients with type 2 diabetes mellitus and chronic kidney disease, cardiovascular disease, or both. The study was terminated early because of an increased risk of adverse outcomes. Cardiovascular death and stroke were both numerically more frequent in the aliskiren group than in the placebo group and adverse events and serious adverse events of interest (hyperkalaemia, hypotension and renal dysfunction) were more frequently reported in the aliskiren group than in the placebo group.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Quinapril</u></p><p>&nbsp;</p><p>Peak plasma quinapril concentrations are observed within 1 hour of oral administration.&nbsp; The extent of absorption is approximately 60%, and is not influenced by food.&nbsp; Following absorption, quinapril is deesterified to its major active metabolite, quinaprilat, and to minor inactive metabolites. Quinapril has an apparent half-life of approximately 1 hour.&nbsp; Peak plasma quinaprilat concentrations are observed approximately 2 hours following an oral dose of quinapril.&nbsp; Quinaprilat is eliminated primarily by renal excretion and has an effective accumulation half-life of 7 hours.&nbsp; In patients with renal insufficiency and creatinine clearance of &lt;40 mL/min, peak and trough quinaprilat concentrations increase, time to peak concentration increases, apparent half-life increases, and time to steady state may be delayed.&nbsp; The elimination of quinaprilat is also reduced in elderly patients (&gt;65 years) and correlates well with the impaired renal function which frequently occurs in the elderly (see section 4.2). Studies in rats indicate that Accuzide and its metabolites do not cross the blood-brain barrier.</p><p>&nbsp;</p><p><u>Hydrochlorothiazide</u></p><p><u>&nbsp;</u></p><p>After oral administration of hydrochlorothiazide, diuresis begins within 2 hours, peaks in about 4 hours, and lasts about 6 to 12 hours. Hydrochlorothiazide is excreted unchanged by the kidney.&nbsp; When plasma levels have been followed for at least 24 hours, the plasma half-life has been observed to vary between 4 to 15 hours.&nbsp; At least 61% of the oral dose is eliminated unchanged within 24 hours. Hydrochlorothiazide crosses the placenta but not the blood-brain barrier.</p><p>&nbsp;</p><p>The pharmacokinetics of quinapril has been studied in a single dose study (0.2 mg/kg) in 24 children aged 2.5 months to 6.8 years and a multiple dose study (0.016-0.468 mg/kg) in 38 children aged 5-16 years old, weighing 66-98 kg on average.</p><p>&nbsp;</p><p>As in adults, quinapril was rapidly converted to quinaprilat. Quinaprilat concentrations generally peaked 1 to 2 hours post dose and declined with a mean half-life of 2.3 hours. In infants and young children the exposure following a single 0.2-mg/kg dose is comparable to that observed in adults after a single 10-mg dose. In a multiple dose study in school age and adolescents, the AUC and Cmax values of quinaprilat were observed to increase linearly with increasing dose of quinapril on a mg/kg basis.&rdquo;</p><p><u>&nbsp;</u></p><p><u>Lactation</u></p><p><u>&nbsp;</u></p><p>After a single oral dose of 20 mg of quinapril in six breast-feeding women, the M/P (milk to plasma ratio) for quinapril was 0.12. Quinapril was not detected in milk after 4 hours after the dose. Quinalaprilat milk levels were undetectable (&lt;5 &mu;g/L) at all time points. It is estimated that a breastfed infant would receive about 1.6% of the maternal weight-adjusted dosage of quinapril.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The results of the preclinical tests do not add anything of further significance to the prescriber.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Magnesium carbonate</p><p>Lactose monohydrate</p><p>Povidone</p><p>Crospovidone</p><p>Magnesium stearate</p><p>Candelilla wax,</p><p>Opadry pink OY-S-6937</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Do not use Accuzide after the expiry date which is stated on Blister / Carton label after EXP.


Shelf life: 2 years. 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 25&deg;C.</p><p>Store in the original package.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Double sided aluminium foil blister enclosed in printed carton. Available in pack size of 30.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements for disposal.</p><p>&nbsp;</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Marketing Authorization Holder 

       Pfizer Pharma PFE GmbH, Berlin, Germany


  Manufactured PACKED & RELEASED BY

Pfizer Manufacturing Deutschland GmbH
Betriebsstätte Freiburg
Mooswaldallee 1
79090 Freiburg
  Germany


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                March 2018 
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>